Skip to content
BOE-A-2026-18512 ·3 September 2026 ·Royal Decree Low impact
Administrative

Non-profit entities: regulation of direct grant awards for medicines and medical devices for 2026

Royal Decree 710/2026 regulates the direct award of various grants regarding medicines and medical devices for the 2026 financial year. The regulation allows for the extraordinary financing of non-profit entities providing services outside the market, bypassing competitive bidding processes due to the impossibility of establishing comparative parameters (preamble). The legal framework complies with Law 38/2003 on Subsidies and Royal Decree 887/2006.

In 2 key points

  1. The direct granting of subsidies without competitive bidding is authorised for entities providing services outside the market (exposición de motivos)
  2. The regulation is based on General Law 38/2003 on Subsidies and its Regulation (RD 887/2006) (exposición de motivos)

How it affects those involved

For non-profit organisations operating in the healthcare sector, the regulation guarantees a direct and rapid funding route for activities of public interest, without the need to participate in competitive tenders (explanatory memorandum). Public administrations, through the AEMPS, will streamline resource management for strategic objectives such as pharmacovigilance or the National Plan against Antibiotic Resistance (PRAN).

Lifecycle

2026-09-03PublishedPublished in the BOE
2026-09-04Into forceComes into force (fecha_vigencia (indice oficial del BOE))
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The administrative team reviews your specific situation.

Talk to the administrative team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BMC.
Book your free first meeting